BCL2 and cervical carcinoma: In a human cervical cancer xenograft model, FA treatment was found to reduce tumor weight in a dose-dependent manner, increase miR-34a expression, downregulate Bcl-2 protein expression, and upregulate caspase-3 protein expression [34].